Protega Pharmaceuticals

Protega Pharmaceuticals is a privately-owned specialized pharmaceutical firm dedicated to advancing advancements in the domain of preventing misuse of prescription drugs through continuous innovation. Acknowledging the significant unmet public health demand to address the growing crisis of prescription opioid abuse and misuse, Protega initiated the pioneering of innovative abuse-deterrent technologies. Their primary focus has been on creating innovative abuse-deterrent products. Protide Pharmaceuticals, Inc. is excited to announce the finalization of a distribution agreement with VWR International LLC, a company of Avantor, Inc. Protide is enthusiastic about contributing to VWR's life science catalog with Characterized Cell Growth, Cell Processing, and Cryopreservation solutions. Our sales, technical, scientific advisory, and customer support teams are expected to maintain a professional approach and deliver responsible, valuable, and precise product information. We uphold high standards, environmental protection, prohibition of conflicts of interest, and provide a secure working environment with skilled and dedicated personnel.